EEG Biofeedback as a Treatment for Substance Use Disorders: Review, Rating of Efficacy and Recommendations for Further Research

Autori

  • Tato M. Sokhadze
  • Rex L. Cannon
  • David L. Trudeau

DOI:

https://doi.org/10.1080/10874200802219855

Abstract

Background. Electroencephalographic (EEG) biofeedback has been employed in substance use disorder (SUD) over the last 3 decades. SUD is a complex series of disorders with frequent comorbidities and EEG abnormalities of several types. Methods and Results. EEG biofeedback has been employed in conjunction with other therapies and may be useful in enhancing certain outcomes of therapy. Based on published clinical studies and employing efficacy criteria adapted by the Association for Applied Psychophysiology and Biofeedback and the International Society for Neurofeedback and Research, alpha theta training, either alone for alcoholism or in combination with beta training for stimulant and mixed substance abuse and combined with residential treatment programs, is probably efficacious. Conclusion. Considerations of further research design taking these factors into account are discussed and descriptions of contemporary research are given.

##submission.downloads##

Pubblicato

2016-09-02

Fascicolo

V. 12 N. 1 (2008)

Sezione

SCIENTIFIC FEATURES

Licenza

© International Society for Neurofeedback and Research (ISNR), all rights reserved. This article (the “Article”) may be accessed online from ISNR at no charge. The Article may be viewed online, stored in electronic or physical form, or archived for research, teaching, and private study purposes. The Article may be archived in public libraries or university libraries at the direction of said public library or university library. Any other reproduction of the Article for redistribution, sale, resale, loan, sublicensing, systematic supply, or other distribution, including both physical and electronic reproduction for such purposes, is expressly forbidden. Preparing or reproducing derivative works of this article is expressly forbidden. ISNR makes no representation or warranty as to the accuracy or completeness of any content in the Article.  From 1995 to 2013 the Journal of Neurotherapy was the official publication of ISNR (www. Isnr.org); on April 27, 2016 ISNR acquired the journal from Taylor & Francis Group, LLC. In 2014, ISNR established its official open-access journal NeuroRegulation (ISSN: 2373-0587; www.neuroregulation.org).